Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$149.36M
Total Bought:
$40.36M
Total Sold:
$21.56M
Net Transaction:
+$18.80M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Ishares Tr0 3 MNTH TREASRY
0-3 MTH TREASURY
270,000270,0000$27.07M$27.19M18.21%+$118.8K
Atea Pharmaceuticals, Inc.(AVIR)5,462,0795,536,710+74,631$16.66M$22.37M14.98%+$5.71M
Spdr Ser TrBLOOMBERG 1 3 MO
ST STR BLO 1 ETF
200,000200,0000$18.28M$18.36M12.29%+$82.0K
Adverum Biotechnologies Inc0833,117+833,117$0$11.78M7.89%+$11.78M
Aclaris Therapeutics, Inc.(ACRS)653,1079,395,934+8,742,827$685.8K$11.65M7.80%+$10.97M
Cyteir Therapeutics Inc3,250,0083,654,053+404,045$9.88M$11.00M7.36%+$1.12M
Climb Bio, Inc.(CLYM)2,180,0002,193,742+13,742$5.89M$6.01M4.02%+$124.9K
Avrobio Inc4,001,6274,001,6270$5.44M$5.12M3.43%-$320.1K
Instil Bio, Inc.(TIL)0348,735+348,735$0$3.77M2.52%+$3.77M
Reneo Pharmaceuticals Inc1,314,2292,177,913+863,684$2.10M$3.62M2.42%+$1.51M
Connect Biopharma Hldgs LtdADS2,061,4382,061,338-100$2.43M$3.59M2.40%+$1.15M
Design Therapeutics, Inc.(DSGN)1,029,478879,478-150,000$2.73M$3.54M2.37%+$816.2K
Athira Pharma Inc1,454,362900,000-554,362$3.53M$2.47M1.65%-$1.07M
Oramed Pharmaceuticals Inc.(ORMP)1,261,559844,496-417,063$2.91M$2.47M1.65%-$448.3K
PMV Pharmaceuticals, Inc.(PMVP)01,306,490+1,306,490$0$2.22M1.49%+$2.22M
Astrotech Corp220,410220,4100$1.87M$1.97M1.32%+$101.4K
LENZ Therapeutics, Inc.(LENZ)063,916+63,916$0$1.43M0.96%+$1.43M
Kinnate Biopharma Inc468,210498,851+30,641$1.11M$1.33M0.89%+$217.3K
Arca Biopharma Inc706,930706,9300$1.20M$1.24M0.83%+$42.4K
Forte Biosciences Inc1,761,7021,761,7020$1.45M$1.23M0.82%-$221.1K
Milestone Pharmaceuticals Inc.(MIST)442,352606,145+163,793$738.7K$1.08M0.73%+$346.3K
Verrica Pharmaceuticals Inc.(VRCA)180,000180,0000$1.32M$1.07M0.71%-$252.0K
Lisata Therapeutics, Inc.(LSTA)269,839284,669+14,830$736.7K$888.2K0.59%+$151.5K
Enliven Therapeutics Inc50,00050,100+100$692.0K$881.3K0.59%+$189.3K
Vistagen Therapeutics, Inc.(VTGN)150,000150,0000$771.0K$792.0K0.53%+$21.0K
Nextcure Inc306,465306,4650$349.4K$683.4K0.46%+$334.0K
CalciMedica, Inc.(CALC)145,424160,424+15,000$415.9K$667.4K0.45%+$251.5K
Q32 Bio Inc.(QTTB)024,894+24,894$0$424.2K0.28%+$424.2K
Talis Biomedical Corp42,74342,7430$318.4K$374.0K0.25%+$55.6K
Allovir Inc0200,464+200,464$0$151.3K0.10%+$151.3K
Adverum Biotechnologies Inc4,554,2520-4,554,252$3.43M$0—-$3.43M
Graphite Bio Inc447,4160-447,416$1.17M$0—-$1.17M
Homology Medicines Inc748,1080-748,108$454.9K$0—-$454.9K
Neurogene Inc.(NGNE)24,6660-24,666$478.0K$0—-$478.0K
Rain Oncology Inc1,349,0070-1,349,007$1.62M$0—-$1.62M
Theseus Pharmaceuticals Inc1,108,3200-1,108,320$4.49M$0—-$4.49M
Tourmaline Bio Inc245,5000-245,500$6.43M$0—-$6.43M
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q1 2024 | TickerTrail